CN117327044A - Acrylate monomer with ultralow volume shrinkage and application - Google Patents

Acrylate monomer with ultralow volume shrinkage and application Download PDF

Info

Publication number
CN117327044A
CN117327044A CN202311499370.XA CN202311499370A CN117327044A CN 117327044 A CN117327044 A CN 117327044A CN 202311499370 A CN202311499370 A CN 202311499370A CN 117327044 A CN117327044 A CN 117327044A
Authority
CN
China
Prior art keywords
compound
methyl
volume shrinkage
ketidene
acrylate monomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202311499370.XA
Other languages
Chinese (zh)
Inventor
聂俊
万晓君
朱晓群
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Jicui Photosensitive Electronic Material Research Institute Co ltd
Original Assignee
Jiangsu Jicui Photosensitive Electronic Material Research Institute Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Jicui Photosensitive Electronic Material Research Institute Co ltd filed Critical Jiangsu Jicui Photosensitive Electronic Material Research Institute Co ltd
Priority to CN202311499370.XA priority Critical patent/CN117327044A/en
Publication of CN117327044A publication Critical patent/CN117327044A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F120/10—Esters
    • C08F120/26—Esters containing oxygen in addition to the carboxy oxygen
    • C08F120/28—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F120/10—Esters
    • C08F120/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • C08F120/36—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F122/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
    • C08F122/10—Esters
    • C08F122/12—Esters of phenols or saturated alcohols
    • C08F122/20—Esters containing oxygen in addition to the carboxy oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F122/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
    • C08F122/10—Esters
    • C08F122/12—Esters of phenols or saturated alcohols
    • C08F122/22—Esters containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D133/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Coating compositions based on derivatives of such polymers
    • C09D133/04—Homopolymers or copolymers of esters
    • C09D133/14—Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur or oxygen atoms in addition to the carboxy oxygen
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D135/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least another carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Coating compositions based on derivatives of such polymers
    • C09D135/02—Homopolymers or copolymers of esters
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

The invention relates to a super-type ultrasonic waveThe low volume shrinkage acrylic monomer is characterized by having a chemical structure of any one of the following: wherein R is 1 Is hydrogen or methyl; r is R 2 And R is R 3 Respectively and independently is one of methyl and phenyl, or R 2 And R is R 3 Forming one of cycloalkyl, oxygen-containing heterocycle and nitrogen-containing heterocycle. The structural compound takes glycerol, trimethylolpropane, pentaerythritol, DL-xylose and DL-arabitol as raw materials, and is reacted with cyclic ketones with different structures such as cyclopentanone, cyclohexanone, tetrahydrofuran methyl ketone, acetophenone, N-methyl-4-piperidone and the like by utilizing the ketidene reaction of ketone and hydroxyl groups, so that part of hydroxyl groups in polyhydroxy groups form ketal, and the residual hydroxyl groups are esterified to generate a series of acrylic ester monomers. The acrylate monomer obtained by the invention has lower volume shrinkage rate after solidification.

Description

Acrylate monomer with ultralow volume shrinkage and application
The application is a divisional application of China patent application of the same applicant, the application date of which is 2023, 5, 31, the application number of which is 202310629496.8, and the invention name of which is an acrylate monomer with ultra-low volume shrinkage and application.
Technical Field
The invention relates to the technical field of acrylic ester compounds, in particular to an acrylic ester monomer with ultra-low volume shrinkage and application thereof.
Background
The free radical photo-curing paint, ink and adhesive take (methyl) acrylic ester as raw material, and the (methyl) acrylic ester is converted into carbon-carbon single bond from Van der Waals force due to intermolecular force during polymerization, so that the molecular volume is greatly reduced, the volume is reduced, and the deformation and the adhesive force reduction are easy to occur after the curing. To solve this problem, the current commercial (meth) acrylate monomers are generally achieved by a method of decreasing the double bond density, i.e., increasing the molecular weight, but there are a series of problems such as increase in cost, increase in viscosity, decrease in solubility, and the like. Isobornyl (meth) acrylate has low volume shrinkage, but is costly, odorous and complex in synthesis process. Thus, the development of ultra-low volume shrinkage (meth) acrylate monomers is one of the hot spots in the current photo-curing field.
Disclosure of Invention
In order to solve the technical problem that the acrylate monomer compound is large in volume shrinkage and easy to deform during curing in the prior art, the acrylate monomer with ultra-low volume shrinkage and the application are provided. The acrylate monomer obtained by the invention has lower volume shrinkage rate after solidification.
In order to achieve the above purpose, the invention is realized by the following technical scheme:
an acrylate monomer with ultra-low volume shrinkage is a monofunctional or difunctional photopolymerizable acrylate monomer, and has a chemical structure as shown in any one of the following formulas I-IV:
wherein R is 1 Is hydrogen or methyl;
R 2 and R is R 3 Respectively and independently is one of methyl and phenyl, or R 2 And R is R 3 Forming one of cycloalkyl, oxygen-containing heterocycle and nitrogen-containing heterocycle.
Preferably, monomers of the chemical structure of formula i include compounds 1 to 10 as follows:
preferably, monomers of the chemical structure of formula ii include compounds 10 to 20 as follows:
preferably, monomers of the chemical structure of formula iii include compounds 21 to 30 as follows:
preferably, monomers of the chemical structure of formula iv include compounds 31 to 40 as follows:
preferably, the monomers of formula v chemical structure include compounds 41 to 50 as follows:
the structural compound can be prepared from polyhydroxy compounds such as glycerol, trimethylolpropane, pentaerythritol, DL-xylose, DL-arabitol and the like, and can be prepared into ketals by reacting with cyclic ketones with different structures such as cyclopentanone, cyclohexanone, tetrahydrofuran methyl ketone, acetophenone, N-methyl-4-piperidone and the like by utilizing the ketidene reaction of the ketone and the hydroxyl, and the residual hydroxyl is esterified to generate a series of acrylic ester monomers.
The synthesis method of one of the compounds 1-10 with the chemical structure shown in the formula I comprises the following steps: and (3) carrying out ketidene reaction on two hydroxyl groups in glycerol and one of cyclopentanone, cyclohexanone, tetrahydrofuran methyl ketone, acetophenone and N-methyl-4-piperidone to obtain a ketidene compound containing one hydroxyl group, and then carrying out esterification reaction on the ketidene compound and acryloyl chloride or methacryloyl chloride to obtain one of the compounds 1-10.
The synthesis method of one of the compounds 11-20 with the chemical structure of the formula II comprises the following steps: carrying out ketidene reaction on two hydroxyl groups in trimethylolpropane and one of cyclopentanone, cyclohexanone, tetrahydrofuran methyl ketone, acetophenone and N-methyl-4-piperidone to obtain a ketidene compound containing one hydroxyl group, and carrying out esterification reaction on the ketidene compound and acryloyl chloride or methacryloyl chloride to obtain one of the compounds 11-20.
A method for synthesizing one of the compounds 21-30 having the chemical structure of formula iii: carrying out ketidene reaction on three hydroxyl groups in DL-xylose and one of cyclopentanone, cyclohexanone, tetrahydrofuran methyl ketone, acetophenone and N-methyl-4-piperidone to obtain a ketidene compound containing one hydroxyl group, and then carrying out esterification reaction on the ketidene compound and acryloyl chloride or methacryloyl chloride to obtain one of the compounds 21-30.
The synthesis method of one of the compounds 31-40 with the chemical structure shown in the formula IV comprises the following steps: and (3) carrying out ketidene reaction on two hydroxyl groups in pentaerythritol and one of cyclopentanone, cyclohexanone, tetrahydrofuran methyl ketone, acetophenone and N-methyl-4-piperidone to obtain a ketidene compound containing the two hydroxyl groups, and then carrying out esterification reaction on the ketidene compound and acryloyl chloride or methacryloyl chloride to obtain one of the compounds 31-40.
A method of synthesizing one of the chemical structures 41-50 of formula v above: four hydroxyl groups in DL-arabitol and one of cyclopentanone, cyclohexanone, tetrahydrofuran methyl ketone, acetophenone and N-methyl-4-piperidone are subjected to ketoside reaction to obtain a ketoside compound containing two hydroxyl groups, and then are subjected to esterification reaction with acryloyl chloride or methacryloyl chloride to obtain one of the compounds 41-50.
The relation of the dosage of the above reactions can be known from optimization experiments.
In another aspect, the invention provides the use of the ultra-low volume shrinkage acrylate monomer in a photocurable coating, a photocurable ink, or a photocurable adhesive.
The beneficial technical effects are as follows:
according to the invention, a series of acrylate monomers with lower hydroxyl content and ultra-low volume shrinkage are obtained through ketone fork reaction and esterification reaction, and the structural monomers have the effect of reducing hydrogen bonds in a curing system, so that the viscosity of the curing system is greatly reduced; in addition, as the ketfork reaction generates a five-membered ring structure, and the cyclic ketone also contains a ring structure, more than two ring structures are beneficial to reducing the problem of large volume shrinkage rate of the acrylate monomer after curing; finally, because the solubility of the raw material polyhydroxy compound in the organic solvent is poor, the esterification reaction of the (methyl) acrylic acid and the polyhydroxy compound is not easy to occur, but the invention can change the solubility of the polyhydroxy compound through the ketyl ketone fork reaction of ketalization, thereby being beneficial to the reaction and obtaining the acrylate monomer with ultra-low volume shrinkage and ultra-low viscosity. The series of structural monomers are obtained by utilizing low-price polyol and cyclic ketone to carry out ketidene reaction and then carrying out esterification, the synthesis process is simple and convenient, the viscosity of the obtained monomers is low, and the volume shrinkage after solidification is small.
Detailed Description
The technical solutions of the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention, and it is apparent that the described embodiments are only some embodiments of the present invention, not all embodiments. The following description of at least one exemplary embodiment is merely exemplary in nature and is in no way intended to limit the invention, its application, or uses. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
The numerical values set forth in these examples do not limit the scope of the present invention unless specifically stated otherwise. Techniques, methods known to those of ordinary skill in the relevant art may not be discussed in detail, but should be considered part of the specification where appropriate. In all examples shown and discussed herein, any specific values should be construed as merely illustrative, and not a limitation. Thus, other examples of the exemplary embodiments may have different values.
The experimental methods in the following examples, for which specific conditions are not noted, are generally determined according to national standards; if the national standard is not corresponding, the method is carried out according to the general international standard or the standard requirements set by related enterprises. Unless otherwise indicated, all parts are parts by weight and all percentages are percentages by weight.
Example 1
Synthesis of Compound 2 and Compound 7 of formula I:
(1) Synthesis of Compound 2-iii: in a three-necked flask equipped with a stirrer, a water separator and a thermometer, compound 2-i (50 g,0.51 mol), glycerin (compound 2-ii,51.6g,0.56 mol), p-toluenesulfonic acid hydrate (9.5 g,0.05 mol) and toluene (500 mL) were mixed, slowly warmed to reflux and held for 16 hours, TLC showed disappearance of starting material; the reaction mixture was poured into a saturated aqueous sodium hydrogencarbonate solution (500 mL), and the organic phase was washed with saturated brine, dried over anhydrous sodium sulfate, decolorized with activated carbon, and concentrated to remove the solvent to give 64.5g of Compound 2-iii as a colorless oily product, yield 56% by weight.
The chemical structure of compound 2-iii was tested and the nuclear magnetic characterization results were as follows:
1 HNMR(400MHz,CDCl 3 )δ:4.31-4.25(m,1H)，4.05-3.95(t,1H)，3.80-3.65(m,2H)，3.61-3.45(m,1H)，1.86(s,1H)，1.69-1.50(m,8H)，1.45-1.31(m,2H)；
13 C(400MHz,CDCl 3 )δ:110.9，76.9，66.6，63.2，35.9，26.2，16.2。
(2) Synthesis of Compound 2: in a three-necked flask equipped with a stirrer, a constant pressure dropping funnel and a thermometer, compound 2-iii (50 g,0.22 mol), triethylamine (26.7 g,0.26 mol) and chloroform (500 mL) of step (1) were mixed, and acryloyl chloride (compound 2-iv,22g,0.24 mol) was slowly added dropwise under ice bath, and after the addition was completed, the flask was slowly warmed to room temperature, stirring was continued for 2 hours, and TLC showed disappearance of the starting material; the reaction solution was poured into a saturated aqueous sodium hydrogencarbonate solution, and the organic phase was washed with saturated brine, dried over anhydrous sodium sulfate, decolorized with activated carbon, and the solvent was removed by concentration to give 44g of Compound 2 as a colorless oily product, yield 89% by weight.
The chemical structure of compound 2 was tested and the nuclear magnetic characterization results were as follows:
1 HNMR(400MHz,CDCl 3 )δ:6.39-6.29(d,1H)，6.11-6.05(m,1H)，5.89-5.81(d,1H)，4.44-4.35(m,1H)，4.15-4.05(m,1H)，3.90-3.75(m,1H)，1.88(m,2H)，1.58-1.49(m,4H)，1.44-1.38(m,6H)；
13 C(400MHz,CDCl 3 )δ:166.5，130.2，128.3，113.9，78.7，69.1，65.2，36.9，28.8，16.2。
the synthesis method of the compound 7 is consistent with that of the compound 2, and the compound 7 can be prepared by replacing the acryloyl chloride with the methacryloyl chloride.
Example 2
The synthesis of compound 1 and compound 6 of formula I is as follows:
the synthesis of compound 1 was the same as in example 1: cyclopentanone (compound 1-i) is reacted with glycerol (compound 2-ii) to give compound 1-ii, which is then reacted with acryloyl chloride (compound 2-iv) to give compound 1 in a two-step yield of 60%;
the synthesis of compound 6 was identical to that of compound 1, except that compound 1-ii was reacted with methacryloyl chloride (compound 2-iv) to give compound 6 in a two-step yield of 69%.
The results of the nuclear magnetic characterization of compound 1 are as follows:
1 H NMR(400MHz,CDCl 3 )δ:6.49-6.39(d,1H)，6.18-6.15(m,1H)，5.98-5.91(d,1H)，4.45–4.37(m,1H)，4.19-4.11(m,1H)，4.00-3.98(m,1H)，3.77-3.76(d,1H)，3.74-3.71(d,1H)，1.94-1.88(m,2H)，1.69-1.55(m,6H)。
the nuclear magnetic characterization of compound 6 is as follows:
1 H NMR(400MHz,CDCl 3 )δ:6.15(s,1H)，5.58(s,1H)，4.25-4.19(m,1H)，4.1-4.01(m,2H)，3.87-3.86(d,1H)，3.81-3.79(d,1H)，2.0(s,3H)，1.99-1.89(m,2H)，1.71-1.65(m,6H)。
example 3
Synthesis of Compound 3 (methyl phenyl ketolidene glycerol acrylate) and Compound 8 (methyl phenyl ketolidene glycerol methacrylate) of formula I:
(1) Synthesis of Compound 3-ii: in a three-necked flask equipped with a stirrer, a water separator and a thermometer, compound 3-i (10 g,83.23 mmol), glycerin (compound 2-ii,9.2g,99.9 mmol), p-toluenesulfonic acid hydrate (1.5 g,8 mmol) and toluene (100 mL) were mixed, slowly raised to reflux and kept for 48 hours, the reaction solution was poured into a saturated aqueous sodium bicarbonate solution (100 mL), the organic phase was washed with saturated brine, dried over anhydrous sodium sulfate, and the solvent was removed by concentration, and after separation by column chromatography, 9.3g of the colorless oily product compound 3-ii was obtained in a yield of 45wt%;
the chemical structure of compound 3-ii was tested and the nuclear magnetic characterization results were as follows:
1 HNMR(400MHz,CDCl 3 )δ:7.49-7.22(m,5H)，4.39-4.29(m,1H)，4.20-4.01(m,2H)，3.90-3.55(d,2H)，1.69(d,3H)。
(2) Synthesis of Compound 3: compound 3-ii was reacted with acryloyl chloride, the starting material mole number and reaction conditions were the same as in step (2) of example 1 to give compound 3, which was characterized by the test nuclear magnetism, and the test results for compound 3 were as follows:
1 HNMR(400MHz,CDCl 3 )δ:7.50-7.23(m,5H)，6.41-6.37(d,1H)，6.21-6.15(m,1H)，5.99-5.91(d,1H)，4.41-4.3(m,1H)，4.25-4.15(m,2H)，3.96-3.59(d,2H)，1.74(d,3H)。
compound 3-ii was reacted with methacryloyl chloride, and the number of moles of the material was the same as the reaction conditions in step (2) of example 1, to obtain compound 8.
Example 4
Synthesis of Compound 4 (tetrahydrofuran-3-one-terminal trimethylolpropane methacrylate) and Compound 9 (tetrahydrofuran-3-one-terminal trimethylolpropane methacrylate) of formula I:
(1) Synthesis of Compound 4-ii: in a three-necked flask equipped with a stirrer, a water separator and a thermometer, compound 4-i (5 g,50 mmol), glycerin (compound 2-ii,9.2g,99.9 mmol), p-toluenesulfonic acid hydrate (960 mg,5 mmol) and n-hexane (50 mL) were mixed, slowly raised to reflux and kept for 48 hours, the reaction solution was poured into a saturated aqueous sodium bicarbonate solution (50 mL), the organic phase was washed with saturated brine, dried over anhydrous sodium sulfate, and the solvent was removed by concentration, and after separation by column chromatography, 3.6g of colorless oily product compound 4-ii was obtained in a yield of 41.5wt%;
the chemical structure of compound 4-ii was tested and the nuclear magnetic characterization results were as follows:
1 HNMR(400MHz,CDCl 3 )δ:4.31-4.19(m,2H)，4.15-4.1(m,1H)，3.98-3.55(m,6H)，2.23-1.98(d,2H)。
(2) Compound 4-ii was reacted with acryloyl chloride, the number of moles of starting materials and reaction conditions were the same as in step (2) of example 1 to give compound 4, which was characterized by the test nuclear magnetism, and the test results for compound 4 were as follows:
1 HNMR(400MHz,CDCl 3 )δ:6.36-6.3(d,1H)，6.21-6.11(m,1H)，5.99-5.85(d,1H)，4.35-4.29(m,2H)，4.19-4.11(m,1H)，4.05-3.55(m,6H)，2.29-2.05(d,2H)。
compound 4-ii was reacted with methacryloyl chloride, and the number of moles of starting materials and the reaction conditions were the same as in step (2) of example 1, to obtain compound 9.
Example 5
Synthesis of Compound 5 (N-methyl-4-piperidinoideneglyceryl acrylate) and Compound 10 (N-methyl-4-piperidinoideneglyceryl methacrylate) of chemical Structure I:
the synthesis method is similar to that of the compounds 1-4 (the specific method is the same as that of the step (1) of the example 1), N-methyl-4-piperidone (the compound 5-i) is taken as a raw material to react with glycerin to obtain the compound 5-ii, and then the compound 5 is obtained by respectively reacting acryloyl chloride, wherein the specific preparation route is as follows:
the chemical structure of test compound 5, the nuclear magnetic characterization result is as follows:
1 HNMR(400MHz,CDCl 3 )δ:6.45-6.43(d,1H)，6.10-6.05(m,1H)，5.89-5.80(d,1H)，4.49-4.45(m,1H)，4.41-4.30(d,2H)，4.19-4.11(m,2H)，2.29-2.19(m,7H)，1.88-1.63(m,4H)。
the compound 5-ii was reacted with methacryloyl chloride, and the number of moles of the starting materials and the reaction conditions were the same as in step (2) of example 1 to obtain compound 10.
Example 6
Synthesis of Compounds 11 to 15 and 16 to 20 of the chemical Structure of formula II:
take compound 11 as an example: the synthesis of compound 11 is basically the same as that of compound 1-5, and trimethylolpropane (compound 11-i) is used for replacing glycerol to carry out ketidene reaction with cyclopentanone (compound 1-i), and then acryloyl chloride is used for esterification, and the specific route is as follows:
the nuclear magnetism of compound 11 is characterized as follows:
1 H NMR(400MHz,CDCl 3 )δ:6.41-6.38(d,1H)，6.05-6.0(m,1H)，5.81-5.75(d,1H)，4.11(s,2H)，3.91-3.85(m,2H)，3.67-3.61(m,2H)，1.78-1.7(t,4H)，1.51-1.5(m,4H)，1.26-1.23(m,2H)，0.95-0.9(t,3H)。
compound 16 can be prepared by reacting compound 11-ii with methacryloyl chloride.
Trimethylolpropane (compound 11-i) is reacted with cyclohexanone (compound 2-i), acetophenone (compound 3-i), tetrahydrofuranone (compound 4-i), N-methyl-4-piperidone (compound 5-i) respectively via ketoside reaction, and then acrylic chloride or methacrylic chloride esterification is carried out, thus preparing compounds 12-15 and 17-20 respectively.
Example 7
Preparation of chemical structure compounds 21-25, compounds 26-30 of formula III:
DL-xylose (compound 21-i) is used as a starting material, and is subjected to ketolidean reaction with cyclopentanone (compound 1-i), cyclohexanone (compound 2-i), acetophenone (compound 3-i), tetrahydrofuranone (compound 4-i) and N-methyl-4-piperidone (compound 5-i) respectively, and then is esterified with acryloyl chloride or methacryloyl chloride, so that compound 21-25 and compound 26-30 can be prepared respectively.
The specific route for the synthesis of compound 21 is as follows:
the nuclear magnetism of compound 21 is characterized as follows:
1 H NMR(400MHz,CDCl 3 )δ:6.47-6.41(d,1H)，6.15-6.1(m,1H)，5.91-5.87(d,1H)，6.22-6.15(m,1H)，4.41-4.35(m,1H)，4.11-3.81(m,2H)，3.33-3.26(m,1H)，2.35-2.10(m,2H)，1.89-1.64(m,4H)，1.51-1.46(m,4H)。
example 8
Preparation of chemical structure Compounds 31-40 of formula IV:
taking the synthesis of compound 31 as an example:
(1) Synthesis of Compound 31-ii: in a three-necked flask equipped with a stirrer, a water separator and a thermometer, compound 31-i (50 g,0.367 mol), cyclopentanone (compound 1-i,27.8g,0.33 mol), p-toluenesulfonic acid hydrate (5.8 g,0.03 mol) and toluene (500 mL) were mixed, slowly raised to reflux and kept for 16 hours, and TLC showed disappearance of starting material; the reaction mixture was poured into a saturated aqueous sodium hydrogencarbonate solution (500 mL), and the organic phase was washed with saturated brine, dried over anhydrous sodium sulfate, decolorized with activated carbon, and concentrated to remove the solvent and unreacted cyclopentanone, whereby 40.7g of a colorless oily product compound 31-ii was obtained in a yield of 61wt%.
(2) The compound 31-ii is subjected to esterification reaction with 2 equivalents of acryloyl chloride and 2 equivalents of triethylamine as acid binding agents, the reaction conditions are the same as those of the step (2) of the example 1, the compound 31 can be obtained after column chromatography, the test nuclear magnetism characterization is carried out, and the test result of the compound 31 is as follows:
1 HNMR(400MHz,CDCl 3 )δ:6.44-6.41(d,2H)，6.15-6.07(m,2H)，5.91-5.85(d,2H)，4.07(s,4H)，3.81(s,4H)，1.77(t,4H)，1.51(m,4H)。
compound 36: the compound 31-ii reacts with methacryloyl chloride, the material mole number and the reaction condition are the same as those of the compound 16 in the step (2), and the compound 36 can be obtained after column chromatography, and the nuclear magnetic characterization test result is as follows:
1 H NMR(400MHz,CDCl 3 )δ:6.17(s,2H)，5.61(s,2H)，4.19(s,4H)，3.88(s,4H)，2.01(s,6H)，1.80(t,4H)，1.55(m,4H)。
the synthesis of compounds 32-35 and compounds 37-40 is the same as the preparation of compound 31, except that: the cyclopentanone (compound 1-i) in the step (1) is replaced by cyclohexanone (compound 2-i), acetophenone (compound 3-i), tetrahydrofuranone (compound 4-i) and N-methyl-4-piperidone (compound 5-i), the proportion and the reaction condition of the materials are the same as those of the compound 31, and the compound 32-35 and the compound 37-40 are obtained through ketonic fork, acryloyl chloride or methacryloyl chloride esterification.
Example 9
The preparation of the compound 41-50 with the chemical structure of the formula V is the same as that of the compound 31, DL-arabitol (the compound 41-i) is used as a raw material, and is respectively subjected to ketolidean reaction with cyclopentanone (the compound 1-i), cyclohexanone (the compound 2-i), acetophenone (the compound 3-i), tetrahydrofuranone (the compound 4-i) and N-methyl-4-piperidone (the compound 5-i), and then acrylic chloride or methacrylic chloride is used for esterification, so that the compound 41-50 can be respectively prepared; taking compound 41 as an example, the specific route is as follows:
test examples
Mixing 100 weight parts of the above compounds with 2 weight parts of UVI-1173, uniformly coating on glass sheet, and applying high pressure mercury lamp (lamp distance 5cm, illumination intensity I) 365nm ＝1mW/cm 2 ) The properties of the film obtained after photocuring by irradiation are shown in Table 1.
Shrinkage the shrinkage was measured continuously according to ISO 4216:2021 thermosetting resin and UV curable resin curing shrinkage, and the results were compared with TPDGA and are shown in Table 1.
TABLE 1 TPGDA and the partial monomer viscosities of the invention and the volume shrinkage of the films obtained after photocuring
/>
/>
As can be seen from Table 1, the films formed after photo-curing of a series of monomers according to the present invention have a volume shrinkage of less than 10% and less than that of the conventional TPGDA.
The foregoing is only a preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art, who is within the scope of the present invention, should make equivalent substitutions or modifications according to the technical scheme of the present invention and the inventive concept thereof, and should be covered by the scope of the present invention.

Claims (6)

1. An acrylate monomer with ultra-low volume shrinkage is characterized by having a chemical structure as shown in the following formula II or formula IV:
wherein R is 1 Is hydrogen or methyl;
R 2 and R is R 3 Respectively and independently is one of methyl and phenyl, or R 2 And R is R 3 Forming one of cycloalkyl, oxygen-containing heterocycle and nitrogen-containing heterocycle.
2. An ultra low volume shrinkage acrylate monomer according to claim 1 wherein the monomer of formula ii comprises compounds 10 to 20:
3. the ultra-low volume shrinkage acrylate monomer according to claim 2, wherein the chemical structure of formula ii is synthesized by: and (3) carrying out ketidene reaction on two hydroxyl groups in trimethylolpropane and one of cyclopentanone, cyclohexanone, tetrahydrofuran methyl ketone, acetophenone and N-methyl-4-piperidone to obtain a ketidene compound containing one hydroxyl group, and then carrying out esterification reaction on the ketidene compound and acryloyl chloride or methacryloyl chloride to obtain the product.
4. An ultra low volume shrinkage acrylate monomer according to claim 1 wherein the monomer of formula iv comprises compounds 31 to 40:
5. the ultra-low volume shrinkage acrylate monomer according to claim 4, wherein the chemical structure of formula iv is synthesized by: carrying out ketidene reaction on two hydroxyl groups in pentaerythritol and one of cyclopentanone, cyclohexanone, tetrahydrofuran methyl ketone, acetophenone and N-methyl-4-piperidone to obtain a ketidene compound containing the two hydroxyl groups, and then carrying out esterification reaction on the ketidene compound and acryloyl chloride or methacryloyl chloride to obtain the product.
6. The application of the acrylate monomer with ultra-low volume shrinkage in a photo-curing coating, photo-curing ink or photo-curing adhesive.
CN202311499370.XA 2023-05-31 2023-05-31 Acrylate monomer with ultralow volume shrinkage and application Pending CN117327044A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202311499370.XA CN117327044A (en) 2023-05-31 2023-05-31 Acrylate monomer with ultralow volume shrinkage and application

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202310629496.8A CN116640113A (en) 2023-05-31 2023-05-31 Acrylate monomer with ultralow volume shrinkage and application
CN202311499370.XA CN117327044A (en) 2023-05-31 2023-05-31 Acrylate monomer with ultralow volume shrinkage and application

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN202310629496.8A Division CN116640113A (en) 2023-05-31 2023-05-31 Acrylate monomer with ultralow volume shrinkage and application

Publications (1)

Publication Number Publication Date
CN117327044A true CN117327044A (en) 2024-01-02

Family

ID=87624302

Family Applications (3)

Application Number Title Priority Date Filing Date
CN202310629496.8A Pending CN116640113A (en) 2023-05-31 2023-05-31 Acrylate monomer with ultralow volume shrinkage and application
CN202311495135.5A Pending CN117466907A (en) 2023-05-31 2023-05-31 Acrylate monomer with ultralow volume shrinkage and application
CN202311499370.XA Pending CN117327044A (en) 2023-05-31 2023-05-31 Acrylate monomer with ultralow volume shrinkage and application

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CN202310629496.8A Pending CN116640113A (en) 2023-05-31 2023-05-31 Acrylate monomer with ultralow volume shrinkage and application
CN202311495135.5A Pending CN117466907A (en) 2023-05-31 2023-05-31 Acrylate monomer with ultralow volume shrinkage and application

Country Status (1)

Country Link
CN (3) CN116640113A (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2877215A (en) * 1956-08-10 1959-03-10 Du Pont Reaction product of phosphoric acid with a dioxolane ester-ethylenically unsaturated monomer copolymer and process for making same
JPS6099181A (en) * 1983-11-02 1985-06-03 Toagosei Chem Ind Co Ltd Curable composition
KR100273172B1 (en) * 1998-08-01 2001-03-02 윤덕용 Photoresist using a compound having a dioxaspirocyclic derivative in the acrylic side chain
US20100048761A1 (en) * 2007-01-17 2010-02-25 Kuraray Medical Inc. Polymerizable monomer-containing composition
WO2016097840A1 (en) * 2014-12-18 2016-06-23 Rhodia Poliamida E Especialidades Ltda Glycerol acetal or glycerol ketal ether-ester, production methods, uses, and compositions containing same
WO2018031373A1 (en) * 2016-08-12 2018-02-15 Iowa State University Research Foundation, Inc. Acrylated and acylated or acetalized polyol as a biobased substitute for hard, rigid thermoplastic and thermoplastic and thermoset materials
CN112341425A (en) * 2020-11-06 2021-02-09 广州市嵩达新材料科技有限公司 Photocuring reactive dilution monomer and preparation method and application thereof

Also Published As

Publication number Publication date
CN117466907A (en) 2024-01-30
CN116640113A (en) 2023-08-25

Similar Documents

Publication Publication Date Title
JP6267643B2 (en) Polyfunctional monomer, method for producing polyfunctional monomer, polymerizable composition and product formed therefrom
CN102365260B (en) a-(unsaturated alkoxyalkyl)acrylate composition and process for production thereof
CN107089914B (en) Cardanol-based acrylate reactive diluent and preparation method and application thereof
CN107501463B (en) Ultraviolet self-crosslinking polyacrylate and preparation method thereof
US9353207B2 (en) Alkylphenyl derivatives and application thereof as photoinitiator
Tasdelen et al. Photochemically masked benzophenone: Photoinitiated free radical polymerization by using benzodioxinone
CN114716315A (en) Application of aromatic vinyl alpha-carbonyl acid ester compound as photoinitiator in LED photopolymerization and preparation method thereof
CN117327044A (en) Acrylate monomer with ultralow volume shrinkage and application
WO2024041569A1 (en) Acyloxyphosphine oxime ester compound suitable for deep curing of uv-vis led light sources, method for preparing same, and use thereof
CN110452191B (en) Modified acrylate, preparation method and application of conductive adhesive
TWI798372B (en) Novel bifunctional (meth)acrylate compounds and polymers
JP2016539913A (en) Method for producing methacrylated benzophenone
CN113527138B (en) Para-fluorobenzoyl oxime ester photoinitiator for preparing photochromic material as well as preparation method and application thereof
US5798434A (en) Monomer mixture and method for the preparation thereof
JP4452037B2 (en) New alicyclic vinyl ether
CN103467628A (en) Alpha-hydroxyalkyl phenyl ketone photoinitiator, its preparation method and application
JP4242191B2 (en) (Meth) acrylate, curable composition and cured product
TW201105629A (en) Methacrylate having carboxyl group and manufacturing method thereof
CN115583931B (en) Ether-functionalized coumarin oxime ester compound and preparation and application thereof
JP3333303B2 (en) Resin composition and method for producing the same
CN103435757B (en) A kind of UV coating fluorine-containing epoxy FRP pipe and preparation method thereof
JP2004175769A (en) Pentacyclopentadecanediol and derivative thereof
JP2009084337A (en) Heterocycle-containing polymerizable compound, method of manufacturing the same, and curable composition containing the compound
CN115572229A (en) Preparation method of polymerizable photoinitiator based on alpha-hydroxyketone
CN117624062A (en) Barbiturates structure-containing compound and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination